Consider HIV a CV "Risk Enhancer"

August 2019

Better antiretroviral therapy means more patients living with HIV will face dyslipidemia and CV disease.

HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.

Consider nuances to managing CV risk in patients living with HIV.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote